|
|
Volumn 6, Issue , 2006, Pages
|
|
PET/CT: will it change the way that we use CT in cancer imaging?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARCINOEMBRYONIC ANTIGEN;
DIAGNOSTIC AGENT;
FLUORODEOXYGLUCOSE F 18;
RADIOPHARMACEUTICAL AGENT;
TUMOR MARKER;
ADENOCARCINOMA;
ARTICLE;
CANCER STAGING;
CASE MANAGEMENT;
COLORECTAL TUMOR;
COMPUTER ASSISTED TOMOGRAPHY;
DIAGNOSTIC ERROR;
ECONOMICS;
FOLLOW UP;
HUMAN;
LIVER TUMOR;
LYMPH NODE METASTASIS;
METASTASIS;
METHODOLOGY;
NEOPLASM;
PATHOLOGY;
POSITRON EMISSION TOMOGRAPHY;
PREDICTION AND FORECASTING;
PREVALENCE;
PROBABILITY;
RADIOGRAPHY;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
ADENOCARCINOMA;
CARCINOEMBRYONIC ANTIGEN;
CASE MANAGEMENT;
COLORECTAL NEOPLASMS;
DIAGNOSTIC ERRORS;
FLUORODEOXYGLUCOSE F18;
FOLLOW-UP STUDIES;
HUMANS;
LIVER NEOPLASMS;
LYMPHATIC METASTASIS;
NEOPLASM METASTASIS;
NEOPLASM STAGING;
NEOPLASMS;
POSITRON-EMISSION TOMOGRAPHY;
PREDICTIVE VALUE OF TESTS;
PREVALENCE;
PROBABILITY;
RADIOPHARMACEUTICALS;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, X-RAY COMPUTED;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 35348930613
PISSN: None
EISSN: 14707330
Source Type: Journal
DOI: 10.1102/1470-7330.2006.9012 Document Type: Article |
|
Times cited : (40)
|
|
References (0)
|
